- Corporate Officers - E
- Eli Lilly & Co
Insider Trading History of Eli Lilly & Co
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Eli Lilly & Co since 2011.
This trader's CIK number is 59478.
At the time of last reporting, Eli Lilly & Co was the 10% Owner of Prevail Therapeutics Inc.. (stock ticker symbol PRVL).
Also see all insider trading activities at Prevail Therapeutics Inc..
Note that in the past
ELI LILLY & Co also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at United Therapeutics Corp (UTHR) by Eli Lilly & Co
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | UTHR | 0 | $0 | 238,837 | $12,955,557 | 0 | $0 |
Yearly summary of insider trading at Zymeworks Inc. (ZYME) by Eli Lilly & Co
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | ZYME | 0 | $0 | 250,000 | $4,000,000 | 0 | $0 |
| 2018 | ZYME | 0 | $0 | 808,438 | $11,353,518 | 0 | $0 |
Yearly summary of insider trading at Dermira, Inc. (DERM) by Eli Lilly & Co
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | DERM | 40,926,025 | $767,362,968 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Sigilon Therapeutics, Inc. (SGTX) by Eli Lilly & Co
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | SGTX | 300,000 | $5,400,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Prevail Therapeutics Inc. (PRVL) by Eli Lilly & Co
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | PRVL | 34,284,789 | $771,407,752 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aeglea Biotherapeutics, Inc. (AGLE) by Eli Lilly & Co
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | AGLE | 500,000 | $5,000,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 6 companies by Eli Lilly & Co:
1. United Therapeutics Corp (UTHR)
2. Zymeworks Inc. (ZYME)
3. Dermira, Inc. (DERM)
4. Sigilon Therapeutics, Inc. (SGTX)
5. Prevail Therapeutics Inc. (PRVL)
6. Aeglea Biotherapeutics, Inc. (AGLE)
Table 1. Insider trading of United Therapeutics Corp (UTHR) by Eli Lilly & Co
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-07-06 | UTHR | Sale | 49,103 | 54.99 | 2,700,173 |
| 2011-06-29 | UTHR | Sale | 93,991 | 53.90 | 5,066,114 |
| 2011-06-23 | UTHR | Sale | 95,743 | 54.20 | 5,189,270 |
Table 2. Insider trading of Zymeworks Inc. (ZYME) by Eli Lilly & Co
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-01-31 | ZYME | Sale | 250,000 | 16.00 | 4,000,000 |
| 2018-11-06 | ZYME | Sale | 700,000 | 14.00 | 9,800,000 |
| 2018-09-24 | ZYME | Sale | 2,027 | 16.36 | 33,161 |
| 2018-09-18 | ZYME | Sale | 6,870 | 14.56 | 100,027 |
| 2018-09-14 | ZYME | Sale | 9,009 | 14.58 | 131,351 |
| 2018-09-17 | ZYME | Sale | 6,865 | 14.58 | 100,091 |
| 2018-09-12 | ZYME | Sale | 10,059 | 14.83 | 149,174 |
| 2018-09-13 | ZYME | Sale | 20,900 | 14.32 | 299,288 |
| 2018-09-10 | ZYME | Sale | 4,500 | 14.44 | 64,980 |
| 2018-09-11 | ZYME | Sale | 11,277 | 14.87 | 167,688 |
| 2018-08-31 | ZYME | Sale | 700 | 14.26 | 9,982 |
| 2018-08-29 | ZYME | Sale | 2,312 | 14.26 | 32,969 |
| 2018-08-30 | ZYME | Sale | 3,440 | 14.35 | 49,364 |
| 2018-08-14 | ZYME | Sale | 3,000 | 14.28 | 42,840 |
| 2018-08-10 | ZYME | Sale | 1,898 | 14.28 | 27,103 |
| 2018-08-13 | ZYME | Sale | 4,531 | 14.33 | 64,929 |
| 2018-08-03 | ZYME | Sale | 1,650 | 13.55 | 22,357 |
| 2018-08-02 | ZYME | Sale | 19,400 | 13.31 | 258,214 |
Table 3. Insider trading of Dermira, Inc. (DERM) by Eli Lilly & Co
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-02-20 | DERM | Buy | 40,926,025 | 18.75 | 767,362,968 |
Table 4. Insider trading of Sigilon Therapeutics, Inc. (SGTX) by Eli Lilly & Co
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-12-08 | SGTX | Buy | 300,000 | 18.00 | 5,400,000 |
Table 5. Insider trading of Prevail Therapeutics Inc. (PRVL) by Eli Lilly & Co
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-01-22 | PRVL | Buy | 34,284,789 | 22.50 | 771,407,752 |
Table 6. Insider trading of Aeglea Biotherapeutics, Inc. (AGLE) by Eli Lilly & Co
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-04-12 | AGLE | Buy | 500,000 | 10.00 | 5,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Eli Lilly & Co
(10% Owner of Prevail Therapeutics Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.